Sponsored Research
Andrew Armstrong of Medical Oncology has received an award from the Movember Foundation for a project entitled "International Retrospective Collaborative Analysis of the Impact of Ablative Therapy Directed to the Local Tumor and/or Metastases for Patients with Oligometastatic Prostate Cancer¿." TBD
Vance Fowler of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01." Total funding will be $3,757,863.
Dorothy Sipkins of Hematologic Malignancies and Cellular Therapy has received an award from the National Institutes of Health for a project entitled "R21 Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia." Total funding will be $413,972.
Jason Somarelli of Medical Oncology has received an award from the Department of Defense for a project entitled "Targeting the p38/Snail/PD-L1 axis in hormone-therapy resistance and metastasis." Total funding will be $512,345.
Heather Whitson of Geriatrics has received a sub-award through the American Geriatrics Society for a project entitled "AGS/AGING Learning, Educating, And, Researching National INitiative in Geriatrics (LEARNING) Collaborative." Total funding will be $14,407.
Industry Sponsored Clinical Trials
Manal Abdelmalek of Gastroenterology has received an award from Novo Nordisk, Inc. for a project entitled "NN9931-4553 ESSENCE The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis." Total funding will be $254,496.
Connie Bales of Geriatrics has received an award from Taylor & Francis Group for a project entitled "Taylor & Francis Publishing Agreement." Total funding will be $12,999.
Ahmed Galal of Hematologic Malignancies and Cellular Therapy has received an award from Iovance Biotherapeutics, Inc for a project entitled "A Phase 1/2 Study Evaluating the Safety and Efficacy of IOV-2001 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Total funding will be $178,366.
Jingquan Jia of Medical Oncology has received an award from Xilis, Inc. for a project entitled "A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Cancers." Total funding will be $205,660.
Thomas Leblanc of Hematologic Malignancies and Cellular Therapy has received an award from Deverra Therapeutics for a project entitled "Deverra: Phase 1:DVX201 NK cells in R/R AML High risk MDS or Myeloproliferative Neoplasms." Total funding will be $686,794.
Renato Lopes of Cardiology has received a sub-award () through Parexel International LLC for a project entitled "A Program of Three Studies in Patients With Systemic Lupus Erythematosus." Total funding will be $283,769.
Renato Lopes of Cardiology has received an award from Lexicon Pharmaceuticals for a project entitled "Lexicon SOLOIST - Follow-up." Total funding will be $22,488.
Renato Lopes of Cardiology has received an award from Lexicon Pharmaceuticals for a project entitled "Lexicon SCORED - Follow-up." Total funding will be $21,051.
Niharika Mettu of Medical Oncology has received an award from Aravive, Inc for a project entitled "A Phase 1b/2 Randomized Study of AVB-S6-500 plus Nab-paclitaxel and Gemcitabine in Patients with Locally Advanced, Recurrent, or Metastatic Pancreatic Adenocarcinoma." Total funding will be $220,480.
Thomas Ortel of Hematology has received an award from UCB Biopharma SPRL for a project entitled "A randomized Phase 2 study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of rozanolixizumab relative to placebo in participants with primary antiphospholipid syndrome.." Total funding will be $4,501.
Thomas Ortel of Hematology has received an award from UCB Biopharma for a project entitled "ASP002 A Phase 2, multicenter, open-label extension study to evaluate the long-term safety and tolerability of rozanolixizumab in adult study participants with primary antiphospholipid syndrome.." Total funding will be $3,501.
Jonathan Piccini of Cardiology has received an award from iRhythm Technologies, Inc. for a project entitled "iRhythm Arrhythmia Analysis with Extended Ambulatory Monitoring and Cardiovascular Events." Total funding will be $718,319.
Richard Riedel of Medical Oncology has received an award from Ayala Pharmaceuticals, Inc for a project entitled "A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors." Total funding will be $1,183,580.
Andrew Wang of Cardiology has received an award from Cytokinetics, Inc. for a project entitled "Redwood - HCM OLE." Total funding will be $335,316.
Chris Woods of Infectious Diseases has received a sub-award hrough Najit Technologies, Inc. for a project entitled "Yellow Fever Vaccine Trial - U44 Clinical Trial with Najit." Total funding will be $403,110.